AU2387997A - Stabilized medicaments containing cysteinyl derivatives - Google Patents

Stabilized medicaments containing cysteinyl derivatives

Info

Publication number
AU2387997A
AU2387997A AU23879/97A AU2387997A AU2387997A AU 2387997 A AU2387997 A AU 2387997A AU 23879/97 A AU23879/97 A AU 23879/97A AU 2387997 A AU2387997 A AU 2387997A AU 2387997 A AU2387997 A AU 2387997A
Authority
AU
Australia
Prior art keywords
stabilized
medicaments containing
derivatives
containing cysteinyl
cysteinyl derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23879/97A
Inventor
Fritz Stanislaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and Co filed Critical Klinge Pharma GmbH and Co
Publication of AU2387997A publication Critical patent/AU2387997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU23879/97A 1997-04-18 1997-04-18 Stabilized medicaments containing cysteinyl derivatives Abandoned AU2387997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/001941 WO1998047534A1 (en) 1997-04-18 1997-04-18 Stabilized medicaments containing cysteinyl derivatives

Publications (1)

Publication Number Publication Date
AU2387997A true AU2387997A (en) 1998-11-13

Family

ID=8166591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23879/97A Abandoned AU2387997A (en) 1997-04-18 1997-04-18 Stabilized medicaments containing cysteinyl derivatives

Country Status (5)

Country Link
EP (1) EP0971743B1 (en)
JP (1) JP2001524087A (en)
AU (1) AU2387997A (en)
DE (1) DE59712694D1 (en)
WO (1) WO1998047534A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037294A2 (en) 1998-01-26 1999-07-29 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
AU5965399A (en) * 1998-10-12 2000-05-01 Andreas Bockelmann Pharmaceutically active composition
IT1303693B1 (en) * 1998-11-03 2001-02-23 Formenti Farmaceutici Spa METAMIZOLE CONTROLLED RELEASE COMPOSITIONS.
DE50005076D1 (en) * 1999-02-11 2004-02-26 Hexal Ag PHARMACEUTICAL, METAMIZOL-CONTAINING SHOWER FORMULA
IT1311921B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
IT1311923B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
IT1311924B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
DE19925499A1 (en) * 1999-06-04 2000-12-07 Beiersdorf Ag Use of ascorbic acid and one or more flavone derivatives and / or flavonone derivatives, in particular flavonoids, for the preparation of cosmetic or dermatological preparations for the prophylaxis or relief of sunburn
SE9904132D0 (en) * 1999-11-16 1999-11-16 Sbl Vaccin Ab Pharmaceutical composition for treatment of diarrhea
IT1318427B1 (en) * 2000-03-27 2003-08-25 A C R Applied Coating Res S A CHEWING RUBBER CONTAINING SULFURATED AMINO ACIDS COMPOUNDS.
NZ524121A (en) * 2000-07-28 2005-09-30 Immupharm Aps Compounds for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
FR2812873B1 (en) 2000-08-11 2003-08-01 Barry Callebaut France PROCESS FOR PRODUCING POLYPHENOLS FROM COCOA BEANS
WO2002024002A2 (en) * 2000-09-22 2002-03-28 Mars Uk Limited Food supplement
FR2815541B1 (en) 2000-10-24 2008-02-29 Lipha USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY
RU2271810C2 (en) * 2000-10-27 2006-03-20 Лео Фарма А/С Compositions for topical using comprising at least one vitamin d or one vitamin d analog and at least one corticosteroid
AT410895B (en) * 2001-01-16 2003-08-25 Fresenius Kabi Austria Gmbh Storage-stable, ready-for-use infusion solution of diclofenac salt, useful for treating acute pain, also containing N-acetyl-L-cysteine, sodium ethylenediamine tetraacetic acid dihydrate and an isotonic agent
JP4592249B2 (en) * 2001-11-30 2010-12-01 江崎グリコ株式会社 Food / drinks and medicines for rheumatic symptoms
HUP0402549A3 (en) * 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
AT413794B (en) * 2002-09-19 2006-06-15 Mayrhofer Pharmazeutika Ges M PHARMACEUTICAL PREPARATION OF DICLOFENAC SODIUM
DE10321029A1 (en) * 2003-05-10 2004-12-02 Sigrid Heide Medicines with selenite
US8349359B2 (en) 2004-11-07 2013-01-08 Your Energy Systems, LLC Liposomal formulation for oral administration of glutathione (reduced)
CA2615319A1 (en) * 2005-07-13 2007-01-18 Al Czap Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
JP5558712B2 (en) * 2005-08-02 2014-07-23 ドロサファーム アクチェンゲゼルシャフト Pharmaceutical composition comprising indomethacin and / or acemetacin
WO2007014476A1 (en) * 2005-08-02 2007-02-08 Drossapharm Ag Pharmaceutical composition containing indometacin and/or acemetacin
CN100464745C (en) * 2006-04-07 2009-03-04 山东轩竹医药科技有限公司 Medication composition of acetyl cysteine or its pharmaceutical salt and asarin
WO2008070121A1 (en) * 2006-12-06 2008-06-12 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
JP2008179632A (en) * 2006-12-29 2008-08-07 Fuji Chem Ind Co Ltd Antioxidant
WO2008081905A1 (en) * 2007-01-05 2008-07-10 Fujifilm Corporation Dispersion composition, cosmetic preparation for skin care, and method for producing dispersion composition
GB0801119D0 (en) 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
JP4908448B2 (en) * 2008-03-26 2012-04-04 ロート製薬株式会社 Pharmaceutical formulation
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
FR2972327B1 (en) * 2011-03-11 2017-08-11 Laboratoires Le Stum MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION
WO2013020600A1 (en) * 2011-08-11 2013-02-14 Cross Sa Pharmaceutical composition comprising a drug containing at least one toxicophore function and n-acetyl-l-cysteine
US11141420B2 (en) 2017-02-24 2021-10-12 Bioactor Bv Flavanones for use in treating visceral hypersensitivity
WO2018191732A1 (en) * 2017-04-14 2018-10-18 Bioelectron Technology Corporation Methods and compositions for treatment of inflammation and oxidative stress
EP4272759A1 (en) * 2021-02-08 2023-11-08 Kyowa Pharma Chemical Co., Ltd. Preventive or therapeutic agent for inflammatory disorders and/or pain disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542309A1 (en) * 1985-11-29 1987-06-04 Cardona Federico Dr Medicinal antioxidant
US5156852A (en) * 1989-04-20 1992-10-20 La Haye Laboratories, Inc. Composition and method for combating macular degeneration
DE69124223T2 (en) * 1990-02-05 1997-04-30 Lifescience Corp FOOD ADDITIVES CONTAINING VITAMINS AND MINERALS
FR2675996B1 (en) * 1991-04-30 1993-10-15 Georges Baritiu COMPLEX SANOGENIC DIETETIC COMPOSITIONS.
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
DE29707005U1 (en) * 1997-04-18 1997-06-26 Klinge Pharma GmbH, 81673 München Stabilized drug containing cysteinyl derivatives

Also Published As

Publication number Publication date
JP2001524087A (en) 2001-11-27
WO1998047534A1 (en) 1998-10-29
EP0971743A1 (en) 2000-01-19
EP0971743B1 (en) 2006-07-12
DE59712694D1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
AU2387997A (en) Stabilized medicaments containing cysteinyl derivatives
AU4892897A (en) Phospholipid drug derivatives
AU7595498A (en) Medicament dispensing cell
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU5902998A (en) Medicine vial dispenser
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU3460297A (en) Taxane derivatives and drugs containing the same
AU5880498A (en) New benzolactam derivatives and medicinal compositions containing the same
AU5387898A (en) Pharmaceutical agents
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU6461599A (en) Packaging for medicaments
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU7813598A (en) Betulinol derivatives
AU6940998A (en) Phospholipid drug derivatives
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU4001297A (en) Capsule
AU9344398A (en) Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof
AU1800100A (en) Medicinal preparations
AU3273497A (en) Inhaling device
AU6115798A (en) Saponarin derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase